tirzepatide drug mounjaro Eli Lilly launches weight-loss in India, beats Novo Nordisk to major market Mounjaro, Zepbound: Why two names

But still, this is way better than paying over $1,000 per month

Its combined mechanism of action is of growing interest within research focused on metabolic disorders, obesity, and insulin resistance

The fundamental difference lies in their receptor targeting: Rybelsus activates only GLP-1 receptors, while Mounjaro works as a dual agonist targeting both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors

This dual action enhances its appetite-suppressing and insulin-regulating effects

on Tirzepatide

The final concentration is calculated using the formula: Total mcg in the vial divided by Total mL of Bac water added